14-day Premium Trial Subscription Sign Up For FreeGet Free

Eyegate Pharmaceuticals Stock Forecast NASDAQ:EYEG

$0.88 (0%)

Volume: 0

Closed: Jan 21, 2022

Hollow Logo Score: 0.000

Eyegate Pharmaceuticals Stock Forecast

$0.88 (0%)

Volume: 0

Closed: Jan 21, 2022

Score Hollow Logo 0.000

Eyegate Pharmaceuticals Company Profile

271 Waverley Oaks Road

Waltham MA 02452



Industry: Biotechnology

Sector: Healthcare

Eyegate Pharmaceuticals


Eyegate Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapeutics and drug delivery systems for treating eye diseases. The company is developing EGP-437 that has completed Phase III clinical trials in anterior uveitis for the treatment of various inflammatory conditions of the eye, including uveitis, a debilitating form of intraocular inflammation of the anterior portion of the uvea. It is also developing Eyegate II drug delivery system. Eyegate Pharmaceuticals, Inc. is based in Waltham, Massachusetts.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE